1. Home
  2. CBUS vs OKYO Comparison

CBUS vs OKYO Comparison

Compare CBUS & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.39

Market Cap

98.5M

Sector

Industrials

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

HOLD

Current Price

$1.49

Market Cap

81.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBUS
OKYO
Founded
2010
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
81.3M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
CBUS
OKYO
Price
$1.39
$1.49
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$9.00
$6.33
AVG Volume (30 Days)
275.4K
60.1K
Earning Date
05-14-2026
07-18-2025
Dividend Yield
N/A
N/A
EPS Growth
74.33
N/A
EPS
N/A
N/A
Revenue
$3,639,000.00
N/A
Revenue This Year
$112.72
N/A
Revenue Next Year
$83.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.09
$1.42
52 Week High
$4.19
$3.35

Technical Indicators

Market Signals
Indicator
CBUS
OKYO
Relative Strength Index (RSI) 52.19 38.73
Support Level $1.20 $1.47
Resistance Level $1.56 $1.73
Average True Range (ATR) 0.11 0.09
MACD 0.02 -0.00
Stochastic Oscillator 75.00 30.43

Price Performance

Historical Comparison
CBUS
OKYO

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: